Home Newsfeeds Needham Reiterates Buy on Peloton Interactive, Maintains $14 Price Target

Needham Reiterates Buy on Peloton Interactive, Maintains $14 Price Target

Needham analyst Bernie McTernan reiterates Peloton Interactive (NASDAQ:PTON) with a Buy and maintains $14 price target.

byBenzinga Newsdesk

February 1, 2023

1 minute read

Needham analyst Bernie McTernan reiterates Peloton Interactive (NASDAQ:PTON) with a Buy and maintains $14 price target.

P/E Ratio Insights for ServiceNow

By Benzinga Insights

January 12, 4:30 PM

In the current session, the stock is trading at $727.18, after a 0.10% increase. Over the past month,…

NOW

Media
News

Melinda Gates Reveals ‘The Most Difficult Times’ During Divorce With Microsoft Co-Founder: ‘There’s Sadness’

By Shanthi Rexaline

August 20, 3:39 PM

Former power couple Melinda and Bill Gates announced their separation in mid-2021, with the divorce coming through in August. Now, Melinda is disclosing certain details regarding the phase of their life around the divorce.

MSFT

Glucotrack Announces Expansion Of Its Continuous Glucose Monitoring Technology To Epidural Glucose Monitoring

By Benzinga Newsdesk

April 16, 8:47 AM

Expansion offers the potential for continuous, discreet and simplified epidural glucose monitoring solutions for patients with Painful Diabetic NeuropathyRutherford, NJ, April 16, 2024 (GLOBE NEWSWIRE) -- Glucotrack,

GCTK

S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is ‘Tricky’

By Shanthi Rexaline

October 3, 6:54 AM

Index futures point to a modestly higher opening on Tuesday, while 10-year Treasury yields have surged to over 4.70%, adding to uncertainty about interest rates.

ALXO

Needham Reiterates Buy on Peloton Interactive, Maintains $14 Price Target

Related Posts

P/E Ratio Insights for ServiceNow

Melinda Gates Reveals ‘The Most Difficult Times’ During Divorce With Microsoft Co-Founder: ‘There’s Sadness’

Glucotrack Announces Expansion Of Its Continuous Glucose Monitoring Technology To Epidural Glucose Monitoring

S&P 500, Nasdaq Futures Waver As Focus Turns To JOLTS Data: Why These Analysts Say Expecting A Strong Q4 This Year Is ‘Tricky’